Co-Diagnostics annual meeting adjourned again due to lack of quorum

Co-Diagnostics, Inc., a NASDAQ-listed company (CODX), was unable to hold its Annual Meeting of Stockholders on Thursday due to a lack of quorum for the second consecutive month, per a SEC filing. The company first attempted the meeting on September 3, 2026, but it fell short of the required quorum, leading to an adjournment to September 24, 2026.

However, on Thursday, the meeting once again failed to reach the necessary quorum, preventing any official business from being conducted. The company's bylaws stipulate that if a quorum is not present, the chairperson can adjourn the meeting without prior warning until one is achieved. Following the latest adjournment, the meeting is now scheduled for September 30, 2026, at 9:00 a.m. Mountain Time, at Co-Diagnostics' headquarters in Salt Lake City, Utah.

According to the SEC filing, shareholders can attend and vote in the same manner as detailed in the company's proxy statement submitted to the SEC on July 21, 2026. Proxies submitted before the reconvened meeting remain valid unless altered or withdrawn prior to voting at the upcoming meeting. The details of this story are drawn from a press release provided to the Securities and Exchange Commission, and have been AI-generated with editorial review.